Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014649
Filing Date
2017-08-01
Accepted
2017-08-01 16:16:16
Documents
68
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fmi-10q_20170630.htm 10-Q 1652193
2 EX-10.1 fmi-ex101_237.htm EX-10.1 34127
3 EX-31.1 fmi-ex311_13.htm EX-31.1 15608
4 EX-31.2 fmi-ex312_12.htm EX-31.2 15422
5 EX-32.1 fmi-ex321_11.htm EX-32.1 5452
  Complete submission text file 0001564590-17-014649.txt   6126812

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fmi-20170630.xml EX-101.INS 1324523
7 XBRL TAXONOMY EXTENSION SCHEMA fmi-20170630.xsd EX-101.SCH 49114
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fmi-20170630_cal.xml EX-101.CAL 39858
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fmi-20170630_def.xml EX-101.DEF 157276
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmi-20170630_lab.xml EX-101.LAB 361860
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmi-20170630_pre.xml EX-101.PRE 270037
Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Filer) CIK: 0001488613 (see all company filings)

EIN.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36086 | Film No.: 17996921
SIC: 8071 Services-Medical Laboratories